Search

 
Start a new search




Results 1-10 of 12.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC1013162016225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate CancerKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; WEIS Mirjam; VERBURG Frederik Anton; MOTTAGHY F; KOPKA Klaus; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC1014062016Ac-225-PSMA-617 for PSMA targeting alpha-radiation therapy of 28 patients with mCRPCKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC1014072016Dose escalation experience with Ac-225-PSMA-617 in PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC1001962016Ac-225-PSMA617 - a single center experience of 40 patients receiving PSMA-targeted alpha therapyKRATOCHWIL Clemens; GIESEL Frederik; BRUCHERTSEIFER Frank; RIUS MONTRAVETA MARIA; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC1009552016Ac-225-PSMA617 PSMA-gerichtete Alpha-Strahler-Therapie des metastasierten ProstatakarzinomsKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; RIUS MONTRAVETA MARIA; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC963782015Ac-225-DOTATOC – dose finding for alpha particle emitter based radionuclide therapy of neuroendocrine tumorsKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS Christos; HABERKORN Uwe; MORGENSTERN Alfred
JRC946512015Ac-225-Dotatoc – Empirische Dosisfindung für die Alphastrahler-basierte Radionuklidtherapie neuroendokriner TumoreKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS Christos; HABERKORN Uwe; MORGENSTERN Alfred
JRC946652015Ac-225-DOTATOC – an empiric dose finding for alpha particle emitter based radionuclide therapy of neuroendocrine tumorsKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS Christos; HABERKORN Uwe; MORGENSTERN Alfred
JRC718162014213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experienceKRATOCHWIL Clemens; GIESEL Frederik; BRUCHERTSEIFER Frank; MIER Walter; APOSTOLIDIS Christos; BOLL Rose; MURPHY Karen; HABERKORN Uwe; MORGENSTERN Alfred
JRC827132013CONTRAST-ENHANCED ULTRASOUND MONITORING OF PERFUSION CHANGES IN HEPATIC NEUROENDOCRINE METASTASES AFTER SYSTEMIC VERSUS SELECTIVE ARTERIAL 177LU/90Y-DOTATOC AND 213BI-DOTATOC RADIOPEPTIDE THERAPYGIESEL Frederik; FLECHSIG Paul; KUDER T; SCHWARTZ L; WULFERT Sarah; ZECHMANN Christian; BRUCHERTSEIFER Frank; HABERKORN Uwe; KRATOCHWIL Clemens
Results 1-10 of 12.

Discover